AG
A. Graham Pockley, PhD
Chief Scientific Officer / Scientific Advisor (Interim)
Radiance BiopharmaRadiance Biopharma Pipeline
| Drug | Indication | Phase |
|---|
| RB-601 | Cancer (tumors expressing c-MET and EGFR) | Pre-clinical |
| RB-203 | Cancer (tumors expressing membrane Hsp70) | Pre-clinical |